(VIANEWS) – Flowers Foods (FLO), Abbott Laboratories (ABT), Diamond Hill Investment Group (DHIL) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Flowers Foods (FLO)
83.5% Payout Ratio
Flowers Foods, Inc. produces and markets packaged bakery products in the United States. It offers fresh breads, buns, rolls, snack cakes, and tortillas, as well as frozen breads and rolls under the Nature's Own, Dave's Killer Bread, Wonder, Canyon Bakehouse, Mrs. Freshley's, and Tastykake brand names. The company distributes its products through a direct-store-delivery distribution and a warehouse delivery system, as well as operates 46 bakeries comprising 44 owned and two leased. Its customers include mass merchandisers, supermarkets and other retailers, convenience stores, national and regional restaurants, quick-serve chains, retail in-store bakeries, foodservice distributors, food wholesalers, institutions, dollar stores, and vending companies. The company was formerly known as Flowers Industries and changed its name to Flowers Foods, Inc. in 2001. Flowers Foods, Inc. was founded in 1919 and is headquartered in Thomasville, Georgia.
Earnings Per Share
As for profitability, Flowers Foods has a trailing twelve months EPS of $0.72.
PE Ratio
Flowers Foods has a trailing twelve months price to earnings ratio of 38.21. Meaning, the purchaser of the share is investing $38.21 for every dollar of annual earnings.
Volume
Today’s last reported volume for Flowers Foods is 206803 which is 91.18% below its average volume of 2346360.
Revenue Growth
Year-on-year quarterly revenue growth grew by 10.1%, now sitting on 4.81B for the twelve trailing months.
Yearly Top and Bottom Value
Flowers Foods’s stock is valued at $27.47 at 20:23 EST, under its 52-week high of $30.16 and way above its 52-week low of $24.15.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Nov 30, 2022, the estimated forward annual dividend rate is 0.88 and the estimated forward annual dividend yield is 3.22%.
2. Abbott Laboratories (ABT)
48.08% Payout Ratio
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Earnings Per Share
As for profitability, Abbott Laboratories has a trailing twelve months EPS of $3.19.
PE Ratio
Abbott Laboratories has a trailing twelve months price to earnings ratio of 30.9. Meaning, the purchaser of the share is investing $30.9 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.28%.
Sales Growth
Abbott Laboratories’s sales growth is negative 18.9% for the ongoing quarter and negative 12.4% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 11, 2023, the estimated forward annual dividend rate is 2.04 and the estimated forward annual dividend yield is 1.85%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 12%, now sitting on 43.65B for the twelve trailing months.
Volume
Today’s last reported volume for Abbott Laboratories is 4004380 which is 21.41% below its average volume of 5095430.
3. Diamond Hill Investment Group (DHIL)
46.12% Payout Ratio
Diamond Hill Investment Group, Inc., together with its subsidiaries, provides investment advisory and fund administration services in the United States. It sponsors, distributes, and offers investment advisory and related services to its clients. The company also provides fund administration services, including portfolio and regulatory compliance, treasury and financial oversight, and general business management and governance of the mutual fund complex, as well as oversight of back-office service providers, such as the custodian, fund accountant, and transfer agent. The company was founded in 1990 and is based in Columbus, Ohio.
Earnings Per Share
As for profitability, Diamond Hill Investment Group has a trailing twelve months EPS of $12.23.
PE Ratio
Diamond Hill Investment Group has a trailing twelve months price to earnings ratio of 12.97. Meaning, the purchaser of the share is investing $12.97 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.41%.
Yearly Top and Bottom Value
Diamond Hill Investment Group’s stock is valued at $158.59 at 20:23 EST, way below its 52-week high of $197.00 and above its 52-week low of $154.24.
4. Canadian National Railway Company (CNI)
39.38% Payout Ratio
Canadian National Railway Company, together with its subsidiaries, engages in rail and related transportation business. The company offers rail services, which include equipment, custom brokage services, transloading and distribution, business development and real estate, and private car storage services; and intermodal services including temperature controlled cargo, port partnership, transloading and distribution, logistic parks, customs brokerage, trucking, and moving grains in containers. It also provides trucking services, such as door-to-door services, import and export dray, interline services, and specialized services comprising flatbed trucks, on-deck mobile transport trays, expedited and temperature controlled cargo, and permit/overweight services; and supply chain services. In addition, it serves automotive, coal, fertilizers, temperature controlled cargo, forest products, dimensional, grain, metal and minerals, petroleum and chemicals, and consumer goods applications. Further, the company operates a network of 20,000 route miles of track and shipping Canada and the United States. Canadian National Railway Company was incorporated in 1919 and is headquartered in Montreal, Canada.
Earnings Per Share
As for profitability, Canadian National Railway Company has a trailing twelve months EPS of $4.03.
PE Ratio
Canadian National Railway Company has a trailing twelve months price to earnings ratio of 28.63. Meaning, the purchaser of the share is investing $28.63 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.2%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 22.5% and 4.9%, respectively.
